Position in INDV
as of Jun 30, 2026
· filed Aug 13, 2026
Position Value
$136,070,166
+$132,668,813 QoQ
Shares Held
3,316,358
+2871.8% QoQ
Ownership
2.81%
of shares outstanding
% of Portfolio
0.03%
of 13F equity value
Holder Rank
#9
of 334 holders
Holding Since
Mar 2026
2 quarters on record
Voting authority
Sole 97%
Shared 0%
None 3%
Common Shares in INDV Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - Specialty & Generic
Healthcare · as of Jun 30, 2026FRANKLIN RESOURCES INC holds $845,206,958 across 34 Drug Manufacturers - Specialty & Generic names. INDV ranks #2 (16.1% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | UTHR |
UNITED THERAPEUTICS Corp
|
340,275 | $184,371,197 | |
| 2 | INDV |
Indivior Pharmaceuticals, Inc.
This page
|
3,316,358 | $136,070,166 | |
| 3 | NBIX |
Neurocrine Biosciences Inc
|
553,068 | $93,214,076 | |
| 4 | VTRS |
Viatris Inc
|
5,658,439 | $89,856,006 | |
| 5 | ZTS |
Zoetis Inc.
|
912,367 | $65,562,688 | |
| 6 | ALKS |
Alkermes plc.
|
1,170,242 | $61,320,679 | |
| 7 | AMLX |
Amylyx Pharmaceuticals, Inc.
|
2,950,225 | $52,986,040 | |
| 8 | RDY |
Dr Reddys Laboratories Ltd
|
2,844,583 | $41,218,006 |
All Filings in INDV
Export CSV
2 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $136,070,166 | 3,316,358 | Shares | Defined | 2026-08-13 | |
| 2026-03-31 | $3,401,353 | 111,593 | Shares | Defined | 2026-05-13 | |
| No filing history on record for this holder in this stock. | ||||||